Related Experiment Video
Updated: Jun 1, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Paraherquamide e.
The crystal structure of 14-deoxy-paraherquamide A reveals specific molecular conformations and hydrogen bonding. This natural product
Area of Science:
- Natural Product Chemistry
- Organic Chemistry
- Crystallography
Background:
- Paraherquamide A is a complex natural product with potential biological activity.
- Understanding the precise three-dimensional structure is crucial for structure-activity relationship studies.
Purpose of the Study:
- To elucidate the crystal structure of 14-deoxy-paraherquamide A.
- To characterize the molecular conformation and intermolecular interactions in the solid state.
Main Methods:
- Single-crystal X-ray diffraction analysis was performed.
- The crystal structure was solved and refined to determine atomic coordinates and bonding information.
Main Results:
- The compound C(28)H(35)N(3)O(4) (14-deoxy-paraherquamide A) was analyzed.
- Pyrrolidine rings adopted envelope conformations; piperazine and piperidine rings exhibited boat conformations.
- Intramolecular C-H⋯O hydrogen bonds and intermolecular N-H⋯O hydrogen bonds forming chains along the b axis were identified.
Conclusions:
- The study provides detailed structural insights into 14-deoxy-paraherquamide A.
- The observed hydrogen bonding network influences the crystal packing and solid-state properties.
More Related Videos
08:56Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
Published on: November 22, 2024
10:29Multi-photon Intracellular Sodium Imaging Combined with UV-mediated Focal Uncaging of Glutamate in CA1 Pyramidal Neurons
Published on: October 8, 2014
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Anthelminthic Agents
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Cholinergic Antagonists: Pharmacokinetics
Antiprotozoal Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...